Related Experiment Video
Updated: Jul 14, 2026
10:37
Development of Recombinant Proteins to Treat Chronic Pain
Published on: April 11, 2018
Protein kinase C in pain: involvement of multiple isoforms
Kandy T Velázquez1, Husam Mohammad, Sarah M Sweitzer
1Department of Pharmacology, Physiology and Neuroscience, University of South Carolina School of Medicine, Columbia, SC 29208, USA.
Pharmacological Research
|June 6, 2007
Summary
Chronic pain, a significant health issue, involves altered pain perception. Protein Kinase C (PKC) isozymes are key targets for developing novel analgesics to treat chronic pain conditions.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Chronic pain is a major global health problem, impacting millions economically and personally.
- It is defined as pain lasting over two months, often unresponsive to conventional treatments.
- Characterized by hypersensitivity (hyperalgesia) and pain from non-painful stimuli (allodynia).
Purpose of the Study:
- To review current research on Protein Kinase C (PKC) involvement in pain and analgesia.
- To synthesize existing data for a mechanistic understanding of PKC in chronic pain.
- To explore PKC isozymes as potential therapeutic targets for novel analgesics.
Main Methods:
- Literature review of studies on PKC isozymes and their role in pain pathways.
- Analysis of research investigating PKC's anatomical localization in pain-processing areas.
- Synthesis of findings to elucidate PKC's regulatory function in pain sensitization.
Main Results:
- PKC isozymes are found in both peripheral and central nervous system sites involved in pain.
- Research over two decades highlights PKC's significant role in pain mechanisms.
- PKC is implicated in the peripheral and central sensitization underlying chronic pain.
Conclusions:
- PKC isozymes represent promising therapeutic targets for managing chronic pain.
- Understanding PKC's role is crucial for developing next-generation analgesic agents.
- Further research into PKC could lead to effective treatments for intractable pain conditions.
Related Concept Videos
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
01:25cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
02:54Protein Kinases and Phosphatases
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...